The Patent Finder

Celcuity Inc.

Also on record
Records under this name other than the patents Celcuity Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.

Showing 1 to 8 of 8 · Back to Celcuity Inc.

PatentTitleStatus Expires Confidence
13/494,618Whole Cell Assays and Methods
Abandoned
Abandoned Jun 11, 2015
AbandonedAbandoned Jun 11, 2015
15/533,897Methods of Measuring Erbb Signaling Pathway Activity to Diagnose and Treat Cancer Patients
Abandoned
Abandoned Jun 5, 2021
AbandonedAbandoned Jun 5, 2021
17/193,891Whole Cell Assays and Methods
Abandoned
Abandoned Aug 8, 2026
AbandonedAbandoned Aug 8, 2026
17/835,208Methods of Treating Cancer Patients with Ras Node or RTK Targeted Therapeutic Agents
Abandoned
Abandoned Jul 11, 2026
AbandonedAbandoned Jul 11, 2026
19/229,722Methods for the Treatment of Cancer Using 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-Dimorpholin-4-YL-1,3,5-Triazin-2-YL)PHENYL]UREA
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/306,599Treatment Regimens for Gedatolisib in Hormonally-Driven Disorders
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/539,411Methods for the Treatment of Cancer Using 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-Dimorpholin-4-YL-1,3,5-Triazin-2-YL)PHENYL]UREA
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/692,517Methods for the Treatment of Cancer Using 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-Dimorpholin-4-YL-1,3,5-Triazin-2-YL)PHENYL]UREA
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited